Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MXC - MGC Pharmaceuticals totally understands CimetrA after MoA study


MXC - MGC Pharmaceuticals totally understands CimetrA after MoA study

(NewsDirect)

MGC Pharmaceuticals Ltd (LSE:MXC,OTC:MGCLF, ASX:MXC) chief medical officer Nadya Lisovoder speaks toProactive's Thomas Warner after announcing the completion of anin-vitro pre-clinical mechanism of action (MoA) study for the Europeanbased bio-pharma company's CimetrA platform.

Lisovoder saysthat the fact MGC "totally understands" CimetrA represents a"very important step" in the developmentprocess.

Contact Details

Proactive UKLtd

+44 20 7989 0813

uk@proactiveinvestors.com

Copyright (c) 2023 TheNewswire - All rights reserved.

Stock Information

Company Name: Mexco Energy Corporation
Stock Symbol: MXC
Market: NYSE
Website: mexcoenergy.com

Menu

MXC MXC Quote MXC Short MXC News MXC Articles MXC Message Board
Get MXC Alerts

News, Short Squeeze, Breakout and More Instantly...